Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion

Journal of Virology

Volumn 79, Issue 7, 2005, Pages 4150-4158

  Coskun, Ayse Kubra ^a   Sutton, Richard E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; GLYCOPROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SYNCYTIUM; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS ENVELOPE; VIRUS TITRATION;

ANIMALS; CATTLE; CELL FUSION; CELL LINE; CELLS, CULTURED; FLOW CYTOMETRY; GIANT CELLS; GLUCOSE TRANSPORTER TYPE 1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; MICROSCOPY, FLUORESCENCE; MONOSACCHARIDE TRANSPORT PROTEINS; RECEPTORS, VIRUS; STAINING AND LABELING;

EID: 15244345590     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.7.4150-4158.2005     Document Type: Article

References (65)

1. Blattner, W. A., D. W. Blayney, G. M. Robert, M. G. Sarngadharan, V. S. Kalyanaraman, P. S. Sarin, E. S. Jaffe, and R. C. Gallo. 1983. Epidemiology of human T-cell leukemia/lymphoma virus. J. Infect. Dis. 147:406-416.
2. Blattner, W. A., V. S. Kalyanaraman, G. M. Robert, T. A. Lister, D. A. Galton, P. S. Sarin, M. H. Crawford, D. Catovsky, M. Greaves, and R. C. Gallo. 1982. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int. J. Cancer 30:257-264.
3. Blayney, D. W., W. A. Blattner, G. M. Robert, E. S. Jaffe, R. I. Fisher, P. J. Bunn, M. G. Patton, H. R. Rarick, and R. C. Gallo. 1983. The human T-cell leukemia-lymphoma virus in the southeastern United States. JAMA 250: 1048-1052.
4. Bolz, S., C. L. Farrell, K. Dietz, and H. Wolburg. 1996. Subcellular distribution of glucose transporter (GLUT-1) during development of the blood-brain barrier in rats. Cell Tissue Res. 284:355-365.
5. Clapham, P., K. Nagy, P. R. Cheingsong, M. Exley, and R. A. Weiss. 1983. Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science 222:1125-1127.
6. Clark, J., C. Saxinger, W. N. Gibbs, W. Lofters, L. Lagranade, K. Deceulaer, A. Ensroth, G. M. Robert, R. C. Gallo, and W. A. Blattner. 1985. Seroepidemiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica. Int. J. Cancer 36:37-41.
7. Dobrogowska, D. H., and A. W. Vorbrodt. 1999. Quantitative immunocytochemical study of blood-brain barrier glucose transporter (GLUT-1) in four regions of mouse brain. J. Histochem. Cytochem. 47:1021-1030.
8. Edlich, R. F., J. A. Arnette, and F. M. Williams. 2000. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J. Emerg. Med. 18:109-119.
9. Gazzolo, L., and D. M. Duc. 1987. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature 326:714-717.
10. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
11. Gordon, N., and R. W. Newton. 2003. Glucose transporter type 1 (GLUT-1) deficiency. Brain Dev. 25:477-480.
12. Gotuzzo, E., C. Arango, A. deq Ueiroz-Campos, and R. E. Isturiz. 2000. Human T-cell lymphotropic virus-I in Latin America. Infect. Dis. Clin. N. Am. 14:211-239, x-xi.
13. Heilig, C. W., T. Saunders, F. C. Brosius III, K. Moley, K. Heilig, R. Baggs, L. Guo, and D. Conner. 2003. Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy. Proc. Natl. Acad. Sci. USA 100:15613-15618.
14. Hinuma, Y., H. Komoda, T. Chosa, T. Kondo, M. Kohakura, T. Takenaka, M. Kikuchi, M. Ichimaru, K. Yunoki, I. Sato, R. Matsuo, Y. Takiuchi, H. Uchino, and M. Hanaoka. 1982. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int. J. Cancer 29:631-635.
15. Ho, D. D., T. R. Rota, and M. S. Hirsch. 1984. Infection of human endothelial cells by human T-lymphotropic virus type I. Proc. Natl. Acad. Sci. USA 81:7588-7590.
16. Holland, A. U., C. Munk, G. R. Lucero, L. D. Nguyen, and N. R. Landau. 2004. Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion. Virology 319:343-352.
17. Hoxie, J. A., D. M. Matthews, and D. B. Cines. 1984. Infection of human endothelial cells by human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 81:7591-7595.
18. Igakura, T., J. C. Stinchcombe, P. K. Goon, G. P. Taylor, J. N. Weber, G. M. Griffiths, Y. Tanaka, M. Osame, and C. R. Bangham. 2003. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713-1716.
19. Jason, J. M., J. S. McDougal, C. Cabradilla, V. S. Kalyanaraman, and B. L. Evatt. 1985. Human T-cell leukemia virus (HTLV-I) p24 antibody in New York City blood product recipients. Am. J. Hematol. 20:129-137.
20. Kalyanaraman, V. S., M. G. Sarngadharan, Y. Nakao, Y. Ho, T. Aoki, and R. C. Gallo. 1982. Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc. Natl. Acad. Sci. USA 79:1653-1657.
21. Kalyanaraman, V. S., M. G. Sarngadharan, B. Poiesz, F. W. Ruscetti, and R. C. Gallo. 1981. Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J. Virol. 38:906-915.
22. Khabbaz, R. F., I. M. Onorato, R. O. Cannon, T. M. Hartley, B. Roberts, B. Hosein, and J. E. Kaplan. 1992. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N. Engl. J. Med. 326:375-380.
23. Kim, F. J., I. Seiliez, C. Denesvre, D. Lavillette, F. L. Cosset, and M. Sitbon. 2000. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus. J. Biol. Chem. 275:23417-23420.
24. Kiyokawa, T., H. Yoshikura, S. Hattori, M. Seiki, and M. Yoshida. 1984. Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions. Proc. Natl. Acad. Sci. USA 81:6202-6206.
25. Maeda, Y., M. Furukawa, Y. Takehara, K. Yoshimura, K. Miyamoto, T. Matsuura, Y. Morishima, K. Tajima, K. Okochi, and Y. Hinuma. 1984. Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study. Int. J. Cancer 33:717-720.
26. Manel, N., F. J. Kim, S. Kinet, N. Taylor, M. Sitbon, and J. L. Battini. 2003. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115:449-459.
27. Manel, N., S. Kinet, J. L. Battini, F. J. Kim, N. Taylor, and M. Sitbon. 2003. The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 101:1913-1918.
28. Manns, A., M. Hisada, and L. La Grenade. 1999. Human T-lymphotropic virus type 1 infection. Lancet 353:1951-1958.
29. Matukonis, M., M. Li, R. P. Molina, B. Paszkiet, M. Kaleko, and T. Luo. 2002. Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems. Hum. Gene Ther. 13:1293-1303.
30. Miyoshi, I., I. Kubonishi, S. Yoshimoto, T. Akagi, Y. Ohtsuki, Y. Shiraishi, K. Nagata, and Y. Hinuina. 1981. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770-771.
31. Moosmann, P., and S. Rusconi. 1996. Alpha complementation of LacZ in mammalian cells. Nucleic Acids Res. 24:1171-1172.
32. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
33. Murphy, E. L., J. P. Figueroa, W. N. Gibbs, A. Brathwaite, C. M. Holding, D. Waters, B. Cranston, B. Hanchard, and W. A. Blattner. 1989. Sexual transmission of human T-lymphotropic virus type 1 (HTLV-1). Ann. Intern. Med. 111:555-560.
34. Nagy, K., P. Clapham, P. R. Cheingsong, and R. A. Weiss. 1983. Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int. J. Cancer 32:321-328.
35. Nakano, S., Y. Ando, K. Saito, I. Moriyama, M. Ichuo, T. Toyama, K. Sugamura, J. Imai, and Y. Hinuma. 1986. Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J. Infect. 12:205-212.
36. Nath, M. D., F. W. Ruscetti, C. Petrow-Sadowski, and K. S. Jones. 2003. Regulation of the cell-surface expression of an HTLV-1 binding protein in human T cells during immune activation. Blood 101:3085-3092.
37. Okochi, K., H. Sato, and Y. Hinuma. 1984. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 46:245-253.
38. Osame, M., M. Matsumoto, K. Usuku, S. Izumo, N. Ijichi, H. Amitani, M. Tara, and A. Igata. 1987. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type 1 and adult T-cell leukemialike cells. Ann. Neurol. 21:117-122.
39. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-1 associated myelopathy, a new clinical entity. Lancet i:1031-1032. (Letter.)
40. Page, K. A., N. R. Landau, and D. R. Littman. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
41. Pardridge, W. M., R. J. Boado, and C. R. Farrell. 1990. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative Western blotting and in situ hybridization. J. Biol. Chem. 265:18035-18040.
42. Pique, C., T. Tursz, and M. C. Dokhelar. 1990. Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation? EMBO J. 9:4243-4248.
43. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
44. Poiesz, B. J., F. W. Ruscetti, M. S. Reitz, V. S. Kalyanaraman, and R. C. Gallo. 1981. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature 294:268-271.
45. Robert-Guroff, M., Y. Nakao, K. Notake, Y. Ito, A. Sliski, and R. C. Gallo. 1982. Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia. Science 215:975-978.
46. Saida, T., K. Saida, M. Funauchi, E. Nishiguchi, M. Nakajima, S. Matsuda, M. Ohta, K. Ohta, H. Nishitani, and M. Hatanaka. 1988. HTLV-I myelitis: isolation of virus, genomic analysis, and infection in neural cell cultures. Ann. N. Y. Acad. Sci. 540:636-638.
47. Saxinger, W., W. A. Blattner, P. H. Levine, J. Clark, R. Biggar, M. Hoh, J. Moghissi, P. Jacobs, L. Wilson, R. Jacobson, et al. 1984. Human T-cell leukemia virus (HTLV-1) antibodies in Africa. Science 225:1473-1476.
48. Seidner, G., M. G. Alvarez, J. I. Yeh, K. R. O'Driscoll, J. Klepper, T. S. Stump, D. Wang, N. B. Spinner, M. J. Birnbaum, and D. C. De Vivo. 1998. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat. Genet. 18:188-191.
49. Skop, A. R., H. Liu, J. Yates III, B. J. Meyer, and R. Heald. 2004. Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. Science 305:61-66.
50. Sommerfelt, M. A., and R. A. Weiss. 1990. Receptor interference groups of 20 retroviruses plating on human cells. Virology 176:58-69.
51. Sommerfelt, M. A., B. P. Williams, P. R. Clapham, E. Solomon, P. N. Goodfellow, and R. A. Weiss. 1988. Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science 242:1557-1559.
52. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
53. Stuver, S. O., N. Tachibana, A. Okayama, F. Romano, T. Yokota, and N. Mueller. 1992. Determinants of HTLV-1 seroprevalence in Miyazaki Prefecture, Japan: a cross-sectional study. J. Acquir. Immune Defic. Syndr. 5: 12-18.
54. Sutton, R. E., and D. R. Littman. 1996. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70:7322-7326.
55. Sutton, R. E., H. T. Wu, R. Rigg, E. Bohnlein, and P. O. Brown. 1998. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72:5781-5788.
56. Tajima, K., S. Kamura, S. Ito, M. Ito, M. Nagatomo, K. Kinoshita, and S. Ikeda. 1987. Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based co-operative study in Tsushima, Japan. Int. J. Cancer 40:741-746.
57. Tajima, K., S. Tominaga, T. Suchi, T. Kawagoe, H. Komoda, Y. Hinuma, T. Oda, and K. Fujita. 1982. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Gann 73:893-901.
58. Tanaka, Y., L. Zeng, H. Shiraki, H. Shida, and H. Tozawa. 1991. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type 1 and induction of neutralizing antibody by peptide immunization. J. Immunol. 147:354-360.
59. Wang, D., P. Kranz-Eble, and D. C. De Vivo. 2000. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum. Mutat. 16:224-231.
60. Watanabe, T., M. Seiki, and M. Yoshida. 1984. HTLV type I (U.S. isolate) and ATLV (Japanese isolate) are the same species of human retrovirus. Virology 133:238-241.
61. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
62. Weiss, R. A., P. Clapham, K. Nagy, and H. Hoshino. 1985. Envelope properties of human T-cell leukemia viruses. Curr. Top Microbiol. Immunol. 115: 235-246.
63. Wong-Staal, F., B. Hahn, V. Manzari, S. Colombini, G. Franchini, E. P. Gelmann, and R. C. Gallo. 1983. A survey of human leukaemias for sequences of a human retrovirus. Nature 302:626-628.
64. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.
65. Yoshikura, H., J. Nishida, M. Yoshida, Y. Kitamura, F. Takaku, and S. Ikeda. 1984. Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells. Int. J. Cancer 33:745-749.